Last reviewed · How we verify
Prolotherapy
At a glance
| Generic name | Prolotherapy |
|---|---|
| Also known as | Hypertonic prolotherapy, Prolo, dextrose 10%, Prolotherapy Dextrose |
| Sponsor | Christine M. Kleinert Institute for Hand and Microsurgery |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Dextrose Hydrodissection for Post-Breast Cancer Chest Wall and Axillary Tightness. (NA)
- Comparison of Platelet-Rich Plasma and Prolotherapy for Plantar Fasciitis (NA)
- Comparison of Hyaluronic Acid, Injectable Platelet-Rich Fibrin, and Prolotherapy in TMJ Arthrocentesis (NA)
- Effects of Dextrose Prolotherapy in Rotator Cuff Disease (NA)
- The Ultrasound-Guided Dextrose Prolotherapy in Ehlers-Danlos Syndrome Patients (PHASE3)
- Comparison of Prolotherapy and Rehabilitation Treatments in Low Back Pain (CPRTLBP) (NA)
- Effectiveness Of Alcohol Addition In Ultrasound-Guided Periarticular Sacroiliac Joint Injection (NA)
- Combined Effect of Prolotherapy and Personalized Physical Activity on Knee Osteoarthritis Progression (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Prolotherapy CI brief — competitive landscape report
- Prolotherapy updates RSS · CI watch RSS
- Christine M. Kleinert Institute for Hand and Microsurgery portfolio CI